Navigation Links
Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights
Date:8/7/2008

n circumstances that will occur in the future. Forward-looking statements include, without limitation, statements about:

-- the Company's ability to obtain necessary regulatory approval for Genasense(R) from the U.S. Food and Drug Administration ("FDA") or European Medicines Agency ("EMEA");

-- the safety and efficacy of the Company's products or product candidates;

-- the Company's assessment of its clinical trials;

-- the commencement and completion of clinical trials;

-- the Company's ability to develop, manufacture, license and sell its products or product candidates;

-- the Company's ability to enter into and successfully execute license and collaborative agreements, if any;

-- the adequacy of the Company's capital resources and cash flow projections, the Company's ability to obtain sufficient financing to maintain the Company's planned operations, or the Company's risk of bankruptcy if it is unsuccessful in obtaining such financing or in securing shareholder approval to increase the number of shares authorized for issuance under the Company's certificate of incorporation, as required by the transactional documents in our recent financing;

-- the adequacy of the Company's patents and proprietary rights;

-- the impact of litigation that has been brought against the Company and any proposed settlement of such litigation; and

-- the other risks described under Certain Risks and Uncertainties Related to the Company's Business, as contained in the Company's Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2007 and its most recent quarterly report on Form 10-Q.

CONTACT:

Genta Inves
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Genta Announces Second Quarter 2008 Financial Results and Conference Call
2. Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane
3. Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia
4. Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs
5. Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights
6. Genta Announces Transfer of its Common Stock to the OTC Bulletin Board
7. Genta Announces Pending Transfer of its Common Stock to the Over-the-Counter Bulletin Board
8. Dr. Elizabeth Brown Joins Argenta TEC
9. Syngenta To Build Major Global Biotech Research Center in Beijing, China
10. Genta Restructures Operations to Focus on Priority Initiatives
11. Genta Granted Extension to Achieve Compliance with NASDAQ Listing Requirements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... IAC Industries wants to share with you the ... to set up and furnish a research lab knowing that ... a year’s time. How does a company make choices in ... What is efficient and cost-effective? , The solution was ... The planners at DisperSol determined that the concept of modular ...
(Date:5/16/2013)... Zealand (PRWEB) May 16, 2013 In late ... invited to speak to doctors in China about Appearance ... and NZ, this was her first trip to lecture in ... Hart visited Guangzhou and Fuzhou, home to 12 and 7 ... China is very high at this point in time. As ...
(Date:5/16/2013)... -- The registration deadline has been extended until May 22 ... Conference, the premier conference for bioscience financial officers. The ... San Diego Bayfront. "We are putting ... to make sure as many people as possible have ... , Chief Financial Officer of Mast Therapeutics, Inc. ...
(Date:5/16/2013)... May 16, 2013 Reportlinker.com ... report is available in its catalogue: ... Biomarkers for Acute Coronary Syndromes - ... http://www.reportlinker.com/p01182969/MediPoint-Diagnostic-Cardiac-Biomarkers-for-Acute-Coronary-Syndromes---APAC-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... Coronary Syndromes - APAC Analysis and ...
Breaking Biology Technology:New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8
... part of its ongoing mission to provide comprehensive ... clinical trials, Clinical Financial Services (CFS) is pleased ... Site Activation Services. This revolutionary new service, which ... as global investigator budget and contract management, will ...
... -- China Botanic Pharmaceutical Inc. (NYSE AMEX: ... a developer, manufacturer and distributor of botanical products, ... today announced that the Company successfully showcased its ... fair") recently held in Chengdu, China. ...
... DIEGO, May 17, 2011 Verenium Corporation (Nasdaq: ... on the development and commercialization of high-performance enzymes, today ... MDB Capital Group at the second annual Bright Lights ... Bright Lights Conference is the only conference with an ...
Cached Biology Technology:Clinical Financial Services (CFS) Launches New Service to Streamline Clinical Trial Activation 2China Botanic Exhibits All-Natural Products at the 65th PHARMACHINA Fair 2China Botanic Exhibits All-Natural Products at the 65th PHARMACHINA Fair 3Verenium Receives CLARUS Award at MDB Capital's Bright Lights Conference 2011 2Verenium Receives CLARUS Award at MDB Capital's Bright Lights Conference 2011 3Verenium Receives CLARUS Award at MDB Capital's Bright Lights Conference 2011 4
(Date:5/16/2013)... neuroscientists from Canada and around the world are ... Canadian Neuroscience Meeting will showcase the latest in ... and reveal clues to understanding the disorders that ... research, and this meeting will showcase the best ... world," says Sam David, President of the Canadian ...
(Date:5/16/2013)... outside of the gym. But doctors use the human pulse ... Bao, a professor of chemical engineering at Stanford, has developed ... wider than a postage stamp. The flexible skin-like monitor, worn ... to help doctors detect stiff arteries and cardiovascular problems. , ... heart health and provide doctors a safer method of measuring ...
(Date:5/16/2013)... HAMBURG, Germany , May 16, 2013 ... Customer Value Enhancement Award on Tuesday to ... for its exceptional biometric border control system. ... Sullivan with the Best Practices Award in the category ...  for its cutting edge Biometric   Border Control ...
Breaking Biology News(10 mins):7th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4
... researchers will use grants of state money to develop ... can detect food contamination, design taller wind turbine towers ... the state,s economy. The state Board of Regents ... grants totaling $942,389 from Iowa State,s $1.459 million share ...
... productivity that once was on the rise with warming temperatures ... because of regional drought according to a new study of ... of the rate of the photosynthesis process that green plants ... sugar, oxygen and eventually plant tissue. Compared with a 6 ...
... This release is available in German . ... are packaged in a highly characteristic fashion. Most of the ... are connected to each other by flexible DNA segments, like ... in deciding which genes are actively expressed, and thus which ...
Cached Biology News:Iowa State awards grants to develop health, energy and research technologies 2Iowa State awards grants to develop health, energy and research technologies 3Iowa State awards grants to develop health, energy and research technologies 4Drought drives decade-long decline in plant growth 2Road signs and traffic signals on DNA 2Road signs and traffic signals on DNA 3
... form from a hematopoietic stem cells called ... the bone surface and lowering the surrounding ... 4.5. The bone mineral is then solubilized ... function is controlled primarily by Macrophage Colony-Stimulating ...
... is critical to the maintenance of ... proteins as important and diverse as ... shock and stress response, antigen presentation, ... ion channels, cell cycle regulation, transcription, ...
... includes 1. Scanning of gel(s) 2. ... tryptic in-gel digestion and peptide extraction ... 5. Acquisition of PMF (Peptide Mass ... TOF/TOF) 6. Acquisition of PFF (Peptide ...
... The Vibratome Company has joined forces ... introduce the Vibratome 411301 Tissue Chopper. This ... prepare sections of tissue for metabolic experiments ... and irregular specimens available at biopsy or ...
Biology Products: